AAAAAA
Results:
1-20
|
Results: 20
Authors:
Chastagner, P
Bouffet, E
Grill, J
Kalifa, C
Citation: P. Chastagner et al., What have we learnt from previous phase II trials to help in the management of childhood brain tumours?, EUR J CANC, 37(16), 2001, pp. 1981-1993
Authors:
Reddy, J
Chastagner, P
Fiette, L
Liu, XY
Theze, J
Citation: J. Reddy et al., IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysisin the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation, INT IMMUNOL, 13(2), 2001, pp. 135-147
Authors:
Grill, J
Le Deley, MC
Gambarelli, D
Raquin, MA
Couanet, D
Pierre-Kahn, A
Habrand, JL
Doz, F
Frappaz, D
Gentet, JC
Edan, C
Chastagner, P
Kalifa, C
Citation: J. Grill et al., Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: A multicenter trial of the French Society of Pediatric Oncology, J CL ONCOL, 19(5), 2001, pp. 1288-1296
Authors:
Chastagner, P
Kozin, SV
Taghian, A
Citation: P. Chastagner et al., Topotecan selectively enhances the radioresponse of human small-cell lung carcinoma and glioblastoma multiforme xenografts in nude mice, INT J RAD O, 50(3), 2001, pp. 777-782
Authors:
Chastagner, P
Lozniewski, A
Lascombes, P
Barberi-Heyob, M
Merthes, PM
Merlin, JL
Citation: P. Chastagner et al., Pharmacokinetic longitudinal studies of antibiotics administered via a permanent intraosseous device in micropigs, MED PED ONC, 36(6), 2001, pp. 635-640
Authors:
Rubie, H
Plantaz, D
Coze, C
Michon, J
Frappaz, D
Baranzelli, MC
Chastagner, P
Peyroulet, MC
Hartmann, O
Citation: H. Rubie et al., Localised and unresectable neuroblastoma in infants: Excellent outcome with primary chemotherapy, MED PED ONC, 36(1), 2001, pp. 247-250
Authors:
Doz, F
Gentet, JC
Pein, F
Frappaz, D
Chastagner, P
Moretti, S
Vassal, G
Arditti, J
Van Tellingen, O
Illiadis, A
Catalin, J
Citation: F. Doz et al., Phase I trial and pharmacological study of a 3-hour paclitaxel infusion inchildren with refractory solid tumours: a SFOP study, BR J CANC, 84(5), 2001, pp. 604-610
Authors:
Chastagner, P
Merlin, JL
Marchal, C
Hoffstetter, S
Barberi-Heyob, M
Vassal, G
Duprez, A
Citation: P. Chastagner et al., In vivo potentiation of radiation response by topotecan in human rhabdomyosarcoma xenografted into nude mice, CLIN CANC R, 6(8), 2000, pp. 3327-3333
Authors:
Plantaz, D
Michon, J
Valteau-Couanet, D
Coze, C
Chastagner, P
Bergeron, C
Nelken, B
Martelli, H
Peyroulet, MC
Carpentier, AF
Armari-Alla, C
Pagnier, A
Rubie, H
Citation: D. Plantaz et al., Long-term outcome in children with opsoclonus-myoclonus associated with localized neuroblastoma: a report from the French Society of Pediatric Oncology, ARCH PED, 7(6), 2000, pp. 621-628
Authors:
Hoeffel, JC
Mainard, L
Chastagner, P
Hoeffel, CC
Citation: Jc. Hoeffel et al., Mandibulo-acral dysplasia, SKELETAL RA, 29(11), 2000, pp. 668-671
Authors:
Chastagner, P
Plouvier, E
Eyer, D
Plesiat, P
Lozniewski, A
Sommelet, D
Citation: P. Chastagner et al., Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer, MED PED ONC, 34(4), 2000, pp. 306-308
Authors:
Bouffet, E
Raquin, M
Doz, F
Gentet, JC
Rodary, C
Demeocq, F
Chastagner, P
Lutz, P
Hartmann, O
Kalifa, C
Citation: E. Bouffet et al., Radiotherapy followed by high dose busulfan and thiotepa - A prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas, CANCER, 88(3), 2000, pp. 685-692
Authors:
Minard, V
Hartmann, O
Peyroulet, MC
Michon, J
Coze, C
Defachelle, AS
Lejars, O
Perel, Y
Bergeron, C
Boutard, P
Leverger, G
Stephan, JL
Thyss, A
Chastagner, P
Couillault, G
Devalck, C
Lutz, P
Mechinaud, F
Millot, F
Plantaz, D
Rialland, X
Rubie, H
Citation: V. Minard et al., Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology, BR J CANC, 83(8), 2000, pp. 973-979
Authors:
Doireau, V
Grill, J
Zerah, M
Lellouch-Tubiana, A
Couanet, D
Chastagner, P
Marchal, JC
Grignon, Y
Chouffai, Z
Kalifa, C
Citation: V. Doireau et al., Chemotherapy for unresectable and recurrent intramedullary glial tumours in children (vol 81, pg 835, 1999), BR J CANC, 82(5), 2000, pp. 1122-1122
Authors:
Fomekong, E
Baylac, F
Moret, C
Chastagner, P
Ducrocq, X
Marchal, JC
Citation: E. Fomekong et al., Dysembryoplastic neuroepithelial tumors. Analysis of 16 cases., NEUROCHIRE, 45(3), 1999, pp. 180-189
Authors:
Herblot, S
Chastagner, P
Samady, L
Moreau, JL
Demaison, C
Froussard, P
Liu, XY
Bonnet, J
Theze, J
Citation: S. Herblot et al., IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control, J IMMUNOL, 162(6), 1999, pp. 3280-3288
Authors:
Doireau, V
Grill, J
Zerah, M
Lellouch-Tubiana, A
Couanet, D
Chastagner, P
Marchal, JC
Grignon, Y
Chouffai, Z
Kalifa, C
Citation: V. Doireau et al., Chemotherapy for unresectable and recurrent intramedullary glial tumors inchildren, BR J CANC, 81(5), 1999, pp. 835-840
Authors:
Bouffet, E
Baranzelli, MC
Patte, C
Portas, M
Edan, C
Chastagner, P
Mechinaud-Lacroix, F
Kalifa, C
Citation: E. Bouffet et al., Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience, BR J CANC, 79(7-8), 1999, pp. 1199-1204
Authors:
Taghian, AG
Chastagner, P
Citation: Ag. Taghian et P. Chastagner, Animal models: a tool for research in radiation oncology, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 26-35
Authors:
Chastagner, P
Taghian, A
Marchal, C
Kozin, SV
Hoffstetter, S
Merlin, JL
Duprez, A
Citation: P. Chastagner et al., Effects of combined radiotherapy and topotecan on four human tumor xenografts, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 39-55
Risultati:
1-20
|